The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...
The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.
Here are some of the major companies whose stocks moved on the week’s news.
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
Shares of Moderna Inc. MRNA slid 2.13% to $42.25 Friday, on what proved to be an all-around rough trading session for the ...
Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...
Shares of Moderna Inc. fell over 8% on Wednesday afternoon, paring some of the gains from Tuesday, the stock’s best trading ...